Text Size

Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Department of Health, Executive Yuan, R.O.C. (Taiwan)
National Science Council, Taiwan
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01058811
First received: January 27, 2010
Last updated: NA
Last verified: January 2010
History: No changes posted
  Purpose

Try to find lung cancer stem cells from primary culture of routine surgical resection of lung cancer tissue including cancer cells and stroma cells, then characterization the established cell lines, and compare the difference of stroma cells between tumor part and surrounding part.


Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue: Find Lung Cancer Stem Cells and Test Its Chemotherapy Drug Resistance; Compare Stroma Cell Between Tumor Part and Surrounding Part

Resource links provided by NLM:

MedlinePlus related topics: Cancer Lung Cancer
U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Biospecimen Retention:   Samples With DNA

Routine Surgical resection of lung tumor


Estimated Enrollment: 30
Study Start Date: December 2009
Estimated Study Completion Date: December 2010
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

lung cancer patient

Criteria

Inclusion Criteria:

  • lung cancer patient with surgical resection of lung tumor

Exclusion Criteria:

  • lung cancer patient without surgical resection of lung tumor
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01058811

Contacts
Contact: Chao-Chi Ho, MD PhD +886-2-23123456 ext 51317 ccho1203@ntu.edu.tw

Locations
Taiwan
National Taiwan University Hospital Recruiting
Taipei, Taiwan
Contact: Chao-Chi Ho, MD PhD     +886-2-23123456 ext 51317     ccho1203@ntu.edu.tw    
Sponsors and Collaborators
National Taiwan University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)
National Science Council, Taiwan
Investigators
Study Chair: Chao-Chi Ho, MD PhD National Taiwan University Hospital, Taipei, Taiwan
  More Information

No publications provided

Responsible Party: Chao-Chi Ho, National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT01058811     History of Changes
Other Study ID Numbers: 200912012R
Study First Received: January 27, 2010
Last Updated: January 27, 2010
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
lung cancer

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
 Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 22, 2013